CIC biomaGUNE is a non-profit research organization created to promote scientific research and technological innovation at the highest levels in the Basque Country following the BIOBASQUE policy in order to create a new business sector based on biosciences.
Article: "Designing Multivalent Probes for Tunable Superselective Targeting"
Authors: Galina V. Dubacheva, Tine Curk, Rachel Auzely-Velty, Daan Frenkel, and Ralf P. Richter
Journal: Proc. Natl. Acad. Sci. USA (2015)
Targeting in biomedicine typically relies on the specific binding of a ‘ligand' on a...
The significance of glycosylation to the biopharmaceutical industry
18/05/2015Luis Liz Marzán, nuevo Jefe de Grupo CIBER-BBN en CIC biomaGUNE
15/05/2015A study of CIC biomaGUNE opens the possibility of designing a new generation of nanomaterials that act as probes able to better distinguish different types of cells
07/05/2015The scientific director of CIC biomaGUNE, Luis Liz-Marzán, elected member of the Royal Academy of Sciences
07/05/2015CIC biomaGUNE participates at Pint of Science-Donostia 2015, an international science festival that brings science to pubs more
ESR Position in Nanoimmunology: Nanofunctionalisation of TLR4 agonists and antagonists -Platforms for enhanced delivery with multimodal imaging trackingApplications are invited for a 36 months position as early-stage researcher (ESR) to work on the Marie Skłodowska-Curie Innovative Training Network TOLLerant from May/June 2015. The research, which will be carried out at CIC biomaGUNE (San
Marie Curie postdoctoral possitionCIC bioma GUNE , San Sebastian, Spain has an opening for 2 years Marie Curie postdoctoral possition for an experienced researcher with 4-10 experience within the FP7-PEOPLE-2013-IAPP VIROMA. We are looking for a highly motivated post doctoral
ESR Position: PhD fellowship at CIC biomaGUNE, San Sebastian, SpainApplications are invited for a 36 months position as early-stage researcher (ESR) to work on the Marie Skłodowska-Curie Innovative Training Network IMMUNOSHAPE (Selective Carbohydrate Immunomodulators targeting C-type Lectin Receptors on Antigen more